INMED PHARMACEUTICALS INC. Inventory, Raw Materials, Gross
INMED PHARMACEUTICALS INC. (INM) had Inventory, Raw Materials, Gross of $172.20 thousand as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Inventory
us-gaap:InventoryRawMaterials · last filed 2026-07-02
- 2025-09-30: Inventory, Raw Materials, Gross $172.20K.
- 2025-06-30: Inventory, Raw Materials, Gross $258.30K.
- 2025-03-31: Inventory, Raw Materials, Gross $258.30K.
- 2024-12-31: Inventory, Raw Materials, Gross $172.20K.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2025-09-30 | $172.20K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $258.30K S-4 · filed 2026-07-02 |
| 2025-03-31 | $258.30K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $172.20K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $274.44K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $372.69K S-4 · filed 2026-07-02 |
| 2023-09-30 | $208.74K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $208.74K 10-K · filed 2024-09-30 |
| 2023-03-31 | $387.07K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $208.74K 10-Q · filed 2023-02-17 |
| 2022-09-30 | $292.58K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $292.58K 10-K · filed 2023-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |